Clinical Trials in Atlanta

Showing 2081-2100 of 9,468 trials

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

NCT06208878

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies

CRISPR Therapeutics AG70 participantsStarted Nov 2023

Duarte, California, United States • Los Angeles, California, United States • Stanford, California, United States +19 more locations

COMPLETED< 1 mile

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

NCT04454463

The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.

Liver Diseases

Johns Hopkins Bloomberg School of Public Health1,649 participantsStarted Nov 2020

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +13 more locations

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Find Trials by Condition in Atlanta

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Expanded Access of Sotorasib

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Topical ENS-002 for Atopic Dermatitis in Adults

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma